Assenagon Asset Management
ASND icon

Assenagon Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Assenagon Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
+1,435
New +$335K ﹤0.01% 1096
2022
Q3 		– Sell
-276,348
Closed -$25.7M – 1339
2022
Q2 		$25.7M Buy
+276,348
New +$26M 0.1% 193

Other funds holding ASND

AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
HJIM
Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BFG
Birch Financial Group Keene, New Hampshire $195M AUM 21.04% 1-Year Est. Return

Assenagon Asset Management's ASND Position: Q2 2026 in Review

Assenagon Asset Management opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 1,435 shares worth $383K. The stake represents ﹤0.01% of the portfolio and ranks #1096 among its holdings. This is a return to the name: Assenagon Asset Management previously reported a position in ASND as recently as Q2 2022.

Assenagon Asset Management first reported a position in ASND in Q2 2022 and has held it in 2 quarters since. The position peaked at $25.7M in Q2 2022. 17 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Assenagon Asset Management held 1,435 shares of Ascendis Pharma A/S worth $383K as of Q2 2026.
  • Ascendis Pharma A/S was a new Assenagon Asset Management position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1096 holding.
  • Assenagon Asset Management first reported a position in Ascendis Pharma A/S in Q2 2022 and has held it in 2 quarters since.
  • Assenagon Asset Management's Ascendis Pharma A/S position peaked at $25.7M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.